Bausch Health to Announce First Quarter 2026 Results on April 29, 2026

Rhea-AI Summary

Bausch Health (NYSE:BHC) will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026.

The company will host a live conference call and webcast at 5:00 p.m. U.S. EDT the same day; materials and a replay will be available on the Investor Relations website prior to and after the call.

News Market Reaction – BHC

+7.36%

+7.36% Session close to close

In the Mar 31 session, BHC gained 7.36%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +7.4% in the session following this news. A strong positive reaction aligns with how...

Analysis

The stock moved +7.4% in the session following this news. A strong positive reaction aligns with how scheduling earnings can focus attention on prior results and guidance, such as Q4 2025 revenues of $2.80 billion and 2026 revenue guidance of $10.625–$10.875 billion. Past earnings-date news saw a -2.06% move, so a much larger gain would represent a departure from that history. Investors could weigh whether enthusiasm reflects confidence in upcoming Q1 details or short-term positioning.

Key Figures

Q1 2026 release date: April 29, 2026 Earnings call time: 5:00 p.m. U.S. EDT Q4 2025 revenue: $2.80 billion +5 more

8 metrics

Q1 2026 release date April 29, 2026 Scheduled earnings release after market close

Earnings call time 5:00 p.m. U.S. EDT Q1 2026 conference call and webcast

Q4 2025 revenue $2.80 billion Q4 2025 consolidated revenues, +9% reported, +6% organic

FY 2025 revenue $10.27 billion Full‑year 2025 consolidated revenues, +7% reported, +5% organic

Q4 2025 GAAP net loss $112 million Q4 2025 GAAP net loss

FY 2025 GAAP net income $157 million Full‑year 2025 GAAP net income

FY 2026 revenue guide $10.625–$10.875 billion 2026 revenue guidance provided on Feb 18, 2026

FY 2026 EBITDA guide $3.875–$4.000 billion 2026 adjusted EBITDA guidance from Q4 2025 release

Previous Earnings date Reports

1 past event · Latest: Jan 21 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 21	Earnings date set	Neutral	-2.1%	Announced timing of Q4 and full‑year 2025 results and investor call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The last earnings-date announcement on Jan 21, 2026 was followed by a -2.06% move, suggesting previous mild pressure around such scheduling news.

Recent Company History

Recent news for Bausch Health has focused on product initiatives, corporate events, and financial results. On Feb 18, 2026, the company reported Q4 2025 revenues of $2.80 billion and full‑year revenues of $10.27 billion, with 2026 revenue guidance of $10.625–$10.875 billion. An earlier item on Jan 21, 2026 simply announced the Q4 and full‑year earnings date and led to a -2.06% move. Today’s announcement continues that pattern of scheduling earnings disclosures and investor calls.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LAVAL, QC, March 31, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference Call Details

Date:                                            Wednesday, April 29, 2026

Time:                                            5:00 p.m. U.S. EDT

Webcast:                                      http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn. 

Investor Contact:	Media Contact:
Garen Sarafian	Katie Savastano
ir@bauschhealth.com	corporate.communications@bauschhealth.com
(877) 281-6642 (toll-free)	(908) 541-3785
BHC-FINANCIAL

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-announce-first-quarter-2026-results-on-april-29-2026-302728610.html

SOURCE Bausch Health Companies Inc.

FAQ

When will Bausch Health (BHC) release first quarter 2026 results?

Bausch Health will release first quarter 2026 results after market close on Wednesday, April 29, 2026. According to the company, results will be published that day and supporting materials will be posted on the Investor Relations website prior to the conference call.

What time is the Bausch Health (BHC) Q1 2026 conference call and webcast?

The BHC conference call and webcast is scheduled for 5:00 p.m. U.S. EDT on April 29, 2026. According to the company, the live webcast link and presentation materials will be available on the Investor Relations events page before the call starts.

Where can investors access the Bausch Health (BHC) webcast and replay for Q1 2026?

Investors can access the live webcast and replay on Bausch Health's Investor Relations website at the events-and-presentations page. According to the company, presentation materials will be uploaded prior to the call and a replay will be posted after the event.

Will Bausch Health (BHC) provide presentation materials for the April 29, 2026 call?

Yes, Bausch Health will provide presentation materials on its Investor Relations website before the April 29 conference call. According to the company, slides and related documents will be made available prior to the start of the live webcast and call.

How long after the market close will Bausch Health (BHC) discuss Q1 2026 results?

Bausch Health will discuss results at 5:00 p.m. U.S. EDT on April 29, 2026, after market close. According to the company, the timing places the live call and webcast shortly after markets close to allow investor review of released results.